Costs of Gastrointestinal Events after Outpatient Opioid Treatment for Non-Cancer Pain

Abstract

The economic burden of GI events coincident with opioid treatment is significant for patients with a GI event recorded in claims. Reducing GI adverse effects has potential cost savings for the health-care system.